Page 89 - CIBERES-2015-eng

Most relevant scientific articles
Research Groups
viLLar J., FernánDez r.L., aMBros a., Parra L., BLanCo J., DoMinguez-Berrot a.M. et aL. A clinical classification of the acute respiratory distress syndrome for predicting outcome and guiding medical therapy. Critical Care Medi- cine. 2015;43(2):346-353.
CaBrera-Benitez n.e., vaLLaDares F., garCía-hernan- Dez s., raMos-nuez a., Martín-Barrasa J.L., Martín- ez-saaveDra M.-t. et aL. Altered profile of circulating en- dothelial-derived microparticles in ventilator-induced lung injury. Critical Care Medicine. 2015;43(12):e551-e559.
aCosta-herrera M., Pino-yanes M., BLanCo J., BaLLes- teros J.C., aMBros a., CorraLes a. et aL. Common var-
Highlights
PROJECTS:
PI13/0119: Randomized Study “NAVA in patients with Acute Respiratory Failure”. ISCIII. IP: Jesus Villar. • PI2012 FMM: Randomized Study “Evaluate effectiveness of dexamethasone in patients with ARDS”. Mutua Madrileña Foundation. IP: Jesus Villar • REB11-024: Practice Pattern Variation in Mechani- cal Ventilation in Critically discontinuing Ill. Ministry of Research, Canada. IP: Karen Burns & Jesus Villar • PI11/0623:Genetic susceptibility to asthma. ISCIII. IP: Carlos Flores. • REGPOTFP7-2012-2013-1: IM- BRAIN: Improvement of Biomedical Research and Innovation in Canary Islands. CORDIS. • NAVA in pa- tients with Acute Respiratory Failure. MAQUET. IP: Jesus Villar. • PI- 0279-2012: Identification of genet- ic mechanisms and characterization of functional networks with Systems Biology in hypersensitivity reactions to non-steroids. Junta Andalucía. Co-IP: Carlos Flores. • PI14-00844: Implicaciones de la sus- ceptibilidad genética y alteraciones del microbioma en la patogénesis del ARDS. ISCIII. IP: Carlos Flores.
CONTRACTS FOR RESEARCH PERSONNEL
CD11/00104: Post- Doctoral Sara Borrel. • FI11/00074: Predoctoral Training Health Research • FI12/00493: Predoctoral Training Health Re- search. • CD13/00304: Post- Doctoral Sara Borrel.
iants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis. Critical Care. 2015.
aCosta-herrera M., Lorenzo-Diaz F., Pino-yanes M., CorraLes a., vaLLaDares F., KLassert t.e. et aL. Lung transcriptomics during protective ventilatory support in sepsis-induced acute lung injury. PLoS ONE. 2015;10(7).
viLLar J., CaBrera-Benitez n.e., vaLLaDares F., garCía-hernanDez s., raMos-nuez, Martín-Barrasa J.L. et aL. Tryptase is involved in the development of early ventilator-induced pulmonary fibrosis in sepsis-induced lung injury. Critical Care. 2015;19(1).
PATENTS
Title/Certificate Invention Patent ES2385443, P201031978. • Title/Certificate Invention Patent ES2408281, P201131785 • Title/Certificate Inven- tion Patent ES2481990, P201232075 • Patent Ap- plication: P201531475 “Method to determine geo- graphical origin of a subject”
INTERNATIONAL COLLABORATION:
Arthur Slutsky: Keenan Research Center for Bio- medical Science, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto. • Robert Kacmarek: Department Respiratory Care, Massachusetts Gen- eral Hospital, Boston. • Joe Garcia: Arizona Health Sciences Center, University of Arizona, Tucson. • Shwu-Fan Ma: Section Pulmonary and Critical Care Medicine, University Chicago, Illinois.
OTHER CONSIDERATIONS:
Jesus Villar:Referee for New England Journal Med- icine, AJRCC, Critical Care Medicine, Intensive Care Medicine, Critical Care, Minerva Anestesiologica • Jesus Villar:Member, Editorial Board Intensive Care Monitor, Faculty 1000. • Carlos Flores:Member, Edi- torial Board of ISRN Pulmonology, Clinical Antialler- gy antiinflamatory Drugs.
Institution: Fundación Canaria de Investigación Sanitaria (FUNCANIS)
Contact: Hospital Universitario de Gran Canaria Dr. Negrín · Barranco de la Ballena, S/N. Planta 4a, Ala Sur. 35019 Las Palmas de Gran Canaria · Tel.: 928 449 413 · E.mail: [email protected]
Website: http://www.ciberes.org/
CIBERES I Annual report 2015 I 89